Apresentação oral: Relação entre o uso de anticoncepcionais orais combinados e o câncer de mama

Notas do episódio

Pedro Duarte Moreira Andrade, Camila Baquieti Carminate, Frederico Noboro Figueiredo Nakagawa, Layandra Vittória de Assis, Layara de Assis. Instituto Metropolitano de Ensino Superior do Vale do Aço (IMES UNIVAÇO), Ipatinga-MG. Publicado no Caderno de Anais de Evento | DOI: https://doi.org/10.25248/anais.e6674.2021. Referências: BEABER EF, et al. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarkers Prev, 2015; 23: 755-64. COFFEY K, et al. Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years. Br J Cancer, 2015; 112(9): 1568-1574. MØRCH LS, et al. Contemporary Hormonal Contraception and the Risk of Breast Cancer. New England Journal of Medicine, 2017; 377: 2228-2239. WILLIAMS WV, et al. Association of Combined Estrogen–Progestogen and Progestogen-Only Contraceptives with the Development of Cancer. Linacre Q, 2018; 85: 412-452.